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ClC-3 is a member of the CLC family of anion channels and transporters that localizes
to early and late endosomes as well as to synaptic vesicles (SV). Its genetic disruption in
mousemodels results in pronounced hippocampal and retinal neurodegeneration, suggest-
ing that ClC-3 might be important for normal excitatory and/or inhibitory neurotransmission
in central neurons. To characterize the role of ClC-3 in glutamate accumulation in SV we
compared glutamatergic synaptic transmission in cultured hippocampal neurons fromWT
and Clcn3−/− mice. In Clcn3−/− neurons the amplitude and frequency of miniature as
well as the amplitudes of action-potential evoked EPSCs were significantly increased as
compared to WT neurons. The low-affinity competitive AMPA receptor antagonist γ-DGG
reduced the quantal size of synaptic events more effectively in WT than in Clcn3−/−
neurons, whereas no difference was observed for the high-affinity competitive non-NMDA
antagonist NBQX. Paired pulse ratios of evoked EPSCswere significantly reduced, whereas
the size of the readily releasable pool was not affected by the genetic ablation of ClC-3.
Electron microscopy revealed increased volumes of SV in hippocampi of Clcn3−/− mice.
Our findings demonstrate that ClC-3 controls fast excitatory synaptic transmission by
regulating the amount of neurotransmitter as well as the release probability of SV. These
results provide novel insights into the role of ClC-3 in synaptic transmission and identify
excessive glutamate release as a likely basis of neurodegeneration in Clcn3 / .− −
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INTRODUCTION
Fast synaptic transmission in the mammalian central nervous
system is initiated by the exocytosis of neurotransmitters from
the presynaptic nerve terminal. The specificity and efficiency of
synaptic transmission relies on selective and effective accumula-
tion of neurotransmitters into synaptic vesicles (SV) by vesicular
secondary-active transporters. Vesicular neurotransmitter trans-
porters utilize the electrochemical gradient for protons (Masson
et al., 1999) that is generated by vacuolar ATPases (V-ATPases;
Finbow and Harrison, 1997; Takamori, 2006). V-type ATPases are
electrogenic, and effective acidification of SV thus requires the
additional transport of counter ions to prevent excessive depo-
larization and to decrease energy demand of proton pumping.
Isolated vesicles usually only acidify in the presence of small
anions such as Cl− (Xie et al., 1983), and anion channels or trans-
porters are generally assumed to supportV-ATPase bymaintaining
electroneutrality in intracellular organelles.
ClC-3 is a member of the CLC family of anion channels and
transporters (Jentsch, 2008) that is expressed in various regions
of the central nervous system. Its localization to SV (Stobrawa
et al., 2001; Gronborg et al., 2010) makes ClC-3 a candidate
anion transporter necessary for effective neurotransmitter accu-
mulation. Genetic disruption of ClC-3 results in severe central
neurodegeneration (Stobrawa et al., 2001; Dickerson et al., 2002;
Yoshikawa et al., 2002). This phenotype suggests excessive gluta-
mate release in the absence of ClC-3, however, a recent study did
not observe significant differences in excitatory synaptic trans-
mission between WT and Clcn3−/− mice (Stobrawa et al., 2001),
most likely due to neurodegeneration and secondary downregula-
tion of vesicular glutamate transporters in the studied Clcn3−/−
animals.
To prevent potential interferences of neurodegeneration in
studying glutamatergic synaptic transmission in Clcn3−/− mice
we used cultured hippocampal neurons for our experiments. The
comparison of miniature and evoked excitatory postsynaptic cur-
rents (EPSC) as well as the ultrastructural analysis of SV in WT
and Clcn3−/− neurons demonstrates that ClC-3 modulates the
magnitude of synaptic events by altering the size and glutamate
content as well as the release probability of SV.
MATERIALS AND METHODS
CELL CULTURE
We prepared dissociated cultures from hippocampal pyrami-
dal neurons from WT or Clcn3−/− mice (kindly provided by
Dr. Thomas Jentsch) at postnatal day 1 as described previ-
ously (Guzman et al., 2010). Since Clcn3−/− mice show selective
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degeneration of the hippocampus starting at an age of about
3 weeks (Stobrawa et al., 2001), we performed our experiments
on culture days 14–15 to avoid alterations of neuronal function by
potential ultrastructural alterations.
ELECTROPHYSIOLOGY
Whole-cell voltage clamp recordings were performed on pyrami-
dal neurons fromWT or Clcn3−/− neurons (Guzman et al., 2010)
using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale,
CA, USA). Patch pipettes with resistances between 3 and 4 M
were filled with intracellular solution containing (in millimolars)
137.5 K-gluconate, 11 NaCl, 2 MgATP, 0.2 Na2GTP, 1.1 EGTA, 11
HEPES, 11 D-glucose, pH 7.3. Only cells with access resistances
of 6–10 M were analyzed, and 80–85% of the access resistance
was compensated. Currents were filtered at 5 kHz and digitized
at 50 kHz. The standard extracellular solution consisted of (in
millimolars) 130 NaCl, 10 NaHCO3, 2.4 KCl, 4 CaCl, 4 MgCl2,
10 HEPES, 10 D-glucose, pH 7.4 with NaOH. The osmolarity
of intra- and extracellular solution was adjusted to 310 mOsm
with D-glucose. Action potential-evoked release was studied after
addition of 25 μM bicucullin to the extracellular solution. For
experiments characterizing miniature EPSCs (mEPSCs) the extra-
cellular solution was supplemented with 1 μM tetrodotoxin
(Sigma-Aldrich, Schnelldorf, Germany), 25 μM bicucullin (Tocris
Bioscience, Ellisville, MI, USA) and 25 μM APV [(2R)-amino-
5-phosphonovaleric acid; (2R)-amino-5-phosphonopentanoate;
Tocris Bioscience, Ellisville, MI, USA].
Quantal signals were recorded by clamping neurons to –
70 mV for periods of 60 s. mEPSCs were detected as spontaneous
events with peak amplitudes >15 pA (∼5 times the S.D. of
the background noise, e.g., WT: 3.2 ± 0.08 pA, Clcn3−/−;
3.05 ± 0.09 pA, n = 5) and total charges – estimated as inte-
gral over the mEPSC >25 fC were analyzed using a commercial
software (Mini analysis, Synaptosoft, Version 6.0.3, Decatur, GA,
USA). Action potential-evoked EPSCs were recorded using an
EPC 10 amplifier controlled by PatchMaster (HEKA, Lambrecht,
Pfalz, Germany) software. Cells were clamped to −70 mV, and
EPSCs were elicited from hippocampal neurons by local extracel-
lular stimulation as described (Maximov et al., 2007a). Synaptic
responses were triggered by 0.5 mA/1 ms current injection at
frequency of 0.2 Hz via bipolar electrode (PI2CEA3 concen-
tric bipolar electrode, tip diameter 2–3 μm platinum/iridium,
Hofheim, Germany ) placed at a distance of 200–250 μM
from the patched cell. For paired-pulse experiments, neurons
were stimulated by pairs of extracellular current application
with 20 ms interstimulus interval. Peak current amplitudes
were measured from baseline current amplitudes determined
before the stimulation. EPSCs – evoked by 1 ms stimuli and-
usually had a time-to-peak duration of about 2 ms. Arti-
facts and current peak amplitudes are thus normally easy to
separate (Guzman et al., 2010). Moreover, possible contami-
nations of synaptic currents by stimulation artifacts can be
easily detected by the different time courses of EPSC and arti-
fact. We carefully checked all experiments for deviations of
measured EPSCs from the typical time course with rapid rise
time (20–80% rise time of 0.26–0.50 ms) and decay time con-
stants of 4.6–10.0 ms. EPSCs were analyzed using FitMaster
(HEKA) and Origin (OriginLab, USA) software. For compar-
ison of action potential-evoked postsynaptic currents in WT
and Clcn3−/− cultures were alternatingly studied at the same
setup with the bipolar electrode set to the same distance from
the cell body for all evaluated cells. To estimate the size of the
readily releasable pool (RRP) we measured synaptic responses
evoked by the fast application of hypertonic solution for 5s
(500 mM sucrose) using a gravity-fed fast flow system. To test
for possible differences in postsynaptic glutamate receptor sen-
sitivity we evoked postsynaptic currents in WT and Clcn3−/−
cultures by applying 100 μM L-glutamate glutamate using a
FemtoJet perfusion system (Eppendorf, Germany). In these
experiments a custom-made perfusion pipette was positioned
close to the recording patch-pipette and glutamate was applied
for 100 ms. Experiments were performed in the absence as
well as in the presence of 200 μM γ-DGG added to the bath
solution.
All experiments were performed with at least three different
preparations with WT and Clcn3−/− mice, and all compar-
isons were between cultures from WT and Clcn3−/− litter-
mates. All experiments were performed at room temperature
(22–23◦C).
ELECTRON MICROSCOPY
After transferal to a 200 μm deep aluminum platelet (Microscopy
Services, Flintbek, Germany) fresh hippocampal tissues were
frozen using a Leica HPM 100 (Wetzlar, Germany), followed by
freeze substitution in 0.1% tannic acid at −90◦C for 48 h in a
Leica AFS2 (Wetzlar, Germany). Solutions were then changed to
2% OsO4, and the temperature was raised initially to −20◦C and
after 7 h to 4◦C. Samples were washed in acetone and embedded in
EPON. Fifty nanometers ultrathin sections were post-stained with
4%uranyl acetate and lead citrate (Reynolds, 1963),mounted onto
form var coated copper grids, stained with 4% uranyl acetate and
lead citrate (Reynolds, 1963) and then examined in a Morgagni
TEM (FEI, Hillsboro, OR, USA), operated at 80 kV. Images from
different tissues blocks of the same animal were taken with a 2K
side mounted Veleta CCD camera, binned to 1024 × 1024 pix-
els. Experiments were performed on hippocampi of at least three
different WT and Clcn3−/− animals.
IMMUNOFLUORESCENCE
Neuronal cultures were blocked and permeabilized with 5% goat
serum (Sigma-Aldrich, Schnelldorf, Germany ) and 1% Triton
X100 for 45min after fixation inPBS containing 4%paraformalde-
hyde at room temperature. Primary antibodies against MAP2
(rabbit polyclonal, Synaptic Systems, Göttingen, Germany) and
anti-VGLUT1 (mouse monoclonal, Synaptic Systems, Göttingen,
Germany) were diluted in 1% goat serum and 0.1% Triton X100
in PBS and then added to cells for 60 min. Subsequently, a sec-
ondary antibody linked to Alexa-Fluor 633 and 488 (Invitrogen,
Darmstadt, Germany) was applied for 60 min. After washing
in PBS, coverslips containing cells were either imaged imme-
diately or mounted on a glass slide with 2 μl Fluoromount-G
(SouthernBiotech).
Images were acquired using a Leica DM IRD (Wetzlar, Ger-
many) inverted microscope equipped with a 63× oil objective
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and analyzed with NIH imageJ 1.45. Immuno-positive spots were
determined using a threshold-based detection routine with a
threshold adjusted to dendritic background signals. Immunosig-
nals were quantified as mean fluorescent intensity, and synaptic
density was determined by counting the number of VGLUT1-
stained puncta per 50 μm dendrite length identified by MAP2
staining.
QUANTIFICATION OF PROTEIN EXPRESSION LEVELS
Cell surface expressionof GluR1 receptorswas assayedwith amod-
ification of cell surface biotinylation methods (Du et al., 2004).
Hippocampal cultures obtained from Clcn3−/− mice and WT
litter mate were washed with ice-cold PBS (with calcium and
magnesium pH 7.4; Invitrogen, Darmstadt, Germany) to pre-
vent receptor internalization. After three washes with PBS cells
were incubated with sulfo-NHS-LC biotin (0.25 mg/ml in ice-
cold PBS) (ThermoScientific, Rockford, IL, USA) for 30 min. The
reaction was stopped by removal of the above solution and incu-
bation for 20 min in ice-cold PBS containing 10 mM glycine.
After threefold washing and lysis with RIPA buffer [in millimo-
lars): 20 HEPES, 100 NaCl, 1 EGTA, 1 Na-orthovanadate, 50
NaF, protease inhibitor (Roche), 1% NP40, 1% deoxicholate,
0,1% SDS pH 7.4], biotinylated proteins were precipitated with
immune pure immobilized streptavidin (Pierce, ThermoScien-
tific, Rockford, IL, USA). Biotinylated proteins were separated
in 10% SDS-PAGE gel and transferred to nitrocellulose mem-
brane. Membranes were probed with an anti-GluR1 antibody
(rabbit polyclonal, 1:700, abcam, Cambridge, UK) or anti-actin
(rabbit, poloclonal, 1:1000, sigma, St. Louis, MO, USA) fol-
lowed by peroxidase-conjugated goat anti-rabbit IgG (1:25000,
Invitrogen, Darmstadt, Germany). Immunoreactive bands were
visualized by enhanced chemiluminiscence (ECL, AppliChem,
Darmstadt, Germany) using a GeneGnome chemiluminiscence
imagine system (SYNGENE, Cambridge, UK) and ImageJ soft-
ware.
We compared expression of VGLUT1 mRNA levels in cultured
neurons from fourdifferentWTandClcn3−/−preparations. Total
RNA was prepared using the PureLink RNA Mini Kit (Ambion,
Darmstadt, Germany ). Reverse transcriptionwas performed from
0.1 μg RNA using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems, Darmstadt, Germany), and VGLUT1
mRNA was quantified with the 2−CT method using a spe-
cific TaqManAssay forVGLUT1 (Mm00812886_m1, StepOnePlus
System, Applied Biosystems, Darmstadt, Germany).
STATISTICAL ANALYSIS
All summary data are given as mean ± SEM. Paired Student’s
t analysis was used to test statistical differences with ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001 levels of significance. Authors warrant
that any human and/or animal studies have been approved by an
appropriate institutional review committee.
RESULTS
INCREASED MINIATURE EPSC AMPLITUDES IN Clcn3−/− NEURONS
ARE CAUSED BY ALTERED SYNAPTIC GLUTAMATE CONCENTRATIONS
Figure 1 shows representative whole-cell patch clamp record-
ings from miniature excitatory postsynaptic currents from WT
and Clcn3−/− neurons. Cells were held at −70 mV, and quan-
tal signals were acquired for a period of 60 s in the pres-
ence of 1 μM TTX, 25 μM APV and 25 μM bicuculline.
Miniature excitatory postsynaptic currents (Figure 1A) display
comparable time courses in WT as well as in Clcn3−/− neu-
rons (Figure 1B, insert), but distinct amplitudes (Figure 1C;
WT 28.9 ± 0.6 pA, n = 40 and Clcn3−/− 35.2 ± 1.4 pA,
n = 47, p < 0.001) and frequencies (Figure 1D; WT
2.2 ± 0.3 Hz, n = 40 and Clcn3−/− 4.0 ± 0.5 Hz, n = 47,
p < 0.01) as illustrated by the amplitude frequency distribution in
Figure 1E.
The observed effects on quantal signals might be caused by
changes in the glutamate concentration in the synaptic cleft after
exocytosis of individual glutamatergic vesicles. To probe ClC-3-
dependent alterations in the synaptic glutamate concentration
we took advantage of γ-DGG, a rapidly dissociating competi-
tive antagonist of AMPA receptors which block AMPA receptors
with lower efficacy at higher glutamate concentrations (Liu et al.,
1999). We found that application of 200 μM γ-DGG reduces
the mean peak mEPSC amplitude at WT and mutant neurons,
FIGURE 1 | Quantal glutamatergic signals are altered in Clcn3−/−
neurons. (A) Representative mEPSCs fromWT and Clcn3−/− neurons at a
holding potential of −70 mV. (B) Superimposed representative
spontaneous events recorded fromWT or Clcn3−/− neurons. Averaged
quantal events are shown in red, and a comparison of averaged normalized
mEPSCs fromWT and Clcn3−/− neurons are shown as inset. (C) mEPSC
peak amplitudes and (D) frequencies from Clcn3−/− andWT neurons. Data
are given as mean ± SEM from at least five different cultures. (E)
Cumulative amplitude frequency distribution forWT (black line) and
Clcn3−/− (red line) neurons. (***p < 0.01 and **p < 0.001 t -student),
numbers in the bars represent the number of evaluated cells.
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however, the effect is less pronounced in the Clcn3−/− than
in WT (Figure 2A). The cumulative frequency distribution of
mEPSC amplitudes revealed that γ-DGG shifted the distribution
of events towards lower values in WT than in Clcn3−/− neu-
rons (Figure 2B). The efficiency of the blocker in reducing the
mean peak mEPSC amplitude was ∼1.5 fold stronger for WT than
for Clcn3−/− neurons, as expected for higher glutamate concen-
tration in Clcn3−/− than in WT synaptic clefts. We found that
application of γ-DGG reduces mean peak mEPSC amplitudes by
18 ± 2 % for WT (n = 12, three different cultures), but only by
12 ± 2% (n = 12, three different cultures) for Clcn3−/− neurons
(p < 0.05; Figure 2C).
1,2,3,4-Tetrahydro-6-nitro-2,3-dioxo-benzo[f] quinxaline-7-
sulfonamide (NBQX) is known to block non-NMDA receptors
to the same extent regardless of the glutamate concentration
(Liu et al., 1999). Application of NBQX to WT or Clcn3−/−
cultures attenuated quantal signals (Figure 2E), and shifted the
mEPSC amplitude cumulative frequency distribution to the left
(Figure 2F). However, in contrast to γ-DGG, NBQX inhibi-
tion was not different between WT and Clcn3−/− (Figure 2G;
mean peak mEPSC amplitudes reduction for WT 17.3 ± 1.4%,
n = 11 and Clcn3−/− 19.0 ± 1.7, n = 13, p = 0.22, three
different cultures). Figures 2D,H depict control mean mEPSC
amplitudes from the cultures used in these experiments, illustrat-
ing consistently increased quantal signals in Clcn3−/− neurons in
the absence of blockers. Taken together, our results indicate that
synaptic cleft glutamate concentrations are higher in Clcn3−/−
than in WT neurons.
ALTERED EVOKED NEUROTRANSMITTER RELEASE IN
Clcn3−/− NEURONS
To test whether the absence of ClC-3 also affects evoked synaptic
responses we studied postsynaptic currents after local extracel-
lular stimulation using a concentric bipolar electrode (Maximov
et al., 2007a,b). Upon low frequency electrical stimulation (0.2Hz)
action potential-evoked responses have significantly higher ampli-
tudes in Clcn3−/− than in WT neurons (WT 2.0 ± 0.3 nA, n = 13
and Clcn3−/− 3.1 ± 0.3 nA, n = 14, p = 0.03; Figures 3A,B).
Evoked EPSCs were even increased to a larger extent than quan-
tal signals in Clcn3−/− neurons. This result is in agreement with
the twofold higher mEPSC frequency and suggests that the size
of the RRP of SV and/or released probability might be altered in
FIGURE 2 |The low-affinity competitive AMPA receptor antagonist
γ-DGG blocks mEPSC amplitudes more efficiently in WT than in
Clcn3−/− neurons. (A) Ensemble mEPSC averages from WT (left) or
Clcn3−/− (right) neurons recorded in the absence (black trace) or in the
presence of γ-DGG (red trace). (B) Peak mEPSC amplitude distributions
for WT (left) and Clcn3−/− (right), in the absence (black) or in the
presence of γ-DGG (red). (C) Relative γ-DGG induced mEPSC amplitude
reductions for WT and Clcn3−/−. (D) mEPSC amplitudes from WT and
Clcn3−/− neurons in the absence of γ-DGG. (E) Ensemble mEPSCs
average from WT (left) and Clcn3−/− (right) cells recorded in the absence
(black trace) or in the presence of NBQX (red trace). (F) Peak amplitude
distributions of WT (left) and Clcn3−/− (right) mEPSCs in the absence
(black) or in the presence of NBQX (red). (G) WT and Clcn3−/− mEPSC
peak amplitudes are similarly sensitive to NBQX in (H) mEPSC amplitudes
from WT and Clcn3−/− neurons in the absence of NBQX. Data are given
as means ± SEM from at least three different cultures (**p < 0.01 and
*p < 0.05 t -student) numbers in the bar represent the number of
evaluated cells.
Frontiers in Cellular Neuroscience www.frontiersin.org May 2014 | Volume 8 | Article 143 | 4
Guzman et al. ClC-3 in glutamatergic synaptic transmission
FIGURE 3 | Evoked synaptic signals are larger in Clcn3−/− than inWT
neurons. (A) Averaged evoked EPSCs from hippocampal neurons fromWT
(black trace) or Clcn3−/− neurons (red trace). (B) Mean EPSC amplitudes
fromWT and Clcn3−/− neurons. (C) Representative secretory responses to
stimulation with 500 mOsm sucrose fromWT (black trace) or Clcn3−/−
neurons (red trace). (D) Mean ± SEM for readily releasable pool (RRP)
charges forWT and Clcn3−/− neurons. The RRP charge is defined by the time
integral over the first 1.2 s after the onset of the sucrose response. (E)
Averaged paired-pulse EPSC traces fromWT (black trace) and Clcn3−/− (red
trace) at an inter-stimulus interval of 20 ms. (F) Mean ± SEM from
paired-pulse ratios forWT or Clcn3−/− neurons. (**p < 0.01 and *p < 0.05
t -student), numbers in bars represent the number of analyzed cells.
the Clcn3−/− neurons. We first tested whether genetic ablation
of ClC-3 affects the size of the RRP of SV. There are functionally
distinct fractions of SV within presynaptic nerve terminals. One
fraction, the so-called RRP of vesicles (Rizzoli and Betz, 2005),
encompasses vesicles that are close to release sites and fuse and
release their content first during nerve activity. Vesicles belong-
ing to the RRP also fuse upon application of hypertonic solution
(Rosenmund and Stevens, 1996). Hypertonic shock is the most
frequently used and most established technique to quantify the
RRP in cultured hippocampal neurons (Rizzoli and Betz, 2005).
Moreover, recent work demonstrated that estimation of the RRP
size either by tetanic stimulation or by hypertonic challenge pro-
vides similar results (Stevens and Williams, 2007). We determined
the size of RRP as the integral of the synaptic current elicited by the
application of 500 mM of sucrose for 5s (Figure 3C) and found no
difference between WT and Clcn3−/− (WT 2.2 ± 0.2 nC, n = 20
and Clcn3−/− 1.9 ± 0.2 nC, n = 17, p = 0.15; Figure 3D).
To examine the release probability in WT and Clcn3−/− neu-
rons we used paired-pulse stimulation, i.e., the application of two
pulses in quick succession. In such experiments, high paired pulse
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ratio (PPR, the ratio of the amplitude of the second pulse to that
of the first) indicate low probability of release, whereas synapses
exhibiting lower PPRs are considered to have higher release prob-
ability. We detected a significant reduction in pair pulse ratio
(20 μs interval) in Clcn3−/− neurons when compared to WT
(WT 2 ± 0.16 PPR, n = 8 and Clcn3−/−1.3 ± 0.15 PPR, n = 9,
p = 0.01; Figures 3E,F). We conclude that the absence of ClC-
3 increases not only the glutamate content, but also the release
probability of SV.
CLC-3 REGULATES THE SIZE OF SYNAPTIC VESICLES
Enhanced glutamate release might be associated with enlarged SV
in Clcn3−/− neurons. We performed an ultrastructural analy-
sis of the size of SV at synapses in hippocampal slices from WT
and Clcn3−/− neurons (Figures 4A,B). Synapses can be readily
identified by a heavily stained postsynaptic density in close prox-
imity to presynaptic terminals filled with clusters of SV. Synaptic
vesicle sizes were estimated by measuring the outer vesicle diam-
eter in different blocks of the same animal from at least three
independent preparation, with mean values of WT vesicles of
38.2 ± 0.2 nm (n = 350 SV, 22 synaptic terminals) and of
43.8 ± 0.2 nm in Clcn3−/− neurons (n = 550 SV, 15 synap-
tic terminals, p < 0.001). The distribution of synaptic vesicle
outer diameters exhibits a significant shift towards larger values in
Clcn3−/− neurons (Figure 4B). Assuming a spheroidal geometry
FIGURE 4 | ClC-3 regulates synaptic vesicle size. (A) Representative
electron micrographs forWT and Clcn3−/− synaptic terminals. (B)
Distribution for synaptic vesicle diameters fromWT (black) and Clcn3−/−
(red) neurons. (C) Mean synaptic vesicle volumes fromWT or Clcn3−/−
neurons. Vesicle volumes were calculated from measured diameters
assuming a spherical shape. Means ± SEM from 350WT and 550
Clcn3−/− synaptic vesicles, three independent preparation (∗∗∗p < 0.001,
t -student).
of SV these values correspond to 1.5 fold increased vesicle vol-
umes in knock-out as compared to WT neurons (Figure 4C). The
increased magnitude of synaptic events in Clcn3−/− neurons thus
corresponds morphologically to increased vesicle sizes.
GENETIC ABLATION OF CLC-3 NEITHER AFFECTS THE NUMBER OF
SYNAPSES NOR EXPRESSION OF AMPA RECEPTOR AND VESICULAR
GLUTAMATE TRANSPORTERS
Vesicular glutamate transporters (VGLUTs) are necessary for
glutamate accumulation in SV, and the quantal size of excita-
tory postsynaptic currents is therefore critically dependent on
expression levels of these transporters (Wilson et al., 2005). We
stained WT and Clcn3−/− neurons with anti-VGLUT1 antibod-
ies and estimated protein expression of VGLUT by determining
intensity levels at distinct locations. No differences in event
numbers or in cumulative frequency distributions of VGLUT1
intensities at synapses were found. (WT n = 724 synapses and
Clcn3−/− n = 943 synapses, p = 0.6; Figures 5A,B). Moreover,
mRNA levels of VGLUT1 were not significantly different between
WT and Clcn3−/− neurons (four different cultures, p = 0.52;
Figure 5C).
GluR1 is highly expressed in hippocampal pyramidal neu-
rons and changes in its number are known to alter synaptic
strength (Harms et al., 2005; Han and Stevens, 2009). We deter-
mined total expression levels and surface density of GluR1 AMPA
receptor subunit using western blotting of full lysates and sur-
face biotinylation without any discernible differences between
WT and Clcn3−/− neurons (Figures 5D,E). We furthermore
compared WT and Clcn3−/− postsynaptic currents evoked by
direct application of 100 μM L-glutamate. No difference was
observed between WT (2.9 ± 0.2 nA, n = 7) and Clcn3−/−
(3.1 ± 0.6 nA, n = 6, p = 0.38) neurons. To exclude the
possibility that saturation might have masked possible differ-
ences in receptor activation experiments were repeated in the
presence of 200 μM of γ-DGG. As expected, evoked current
in responses to 100 μM L-glutamate were smaller in the pres-
ence of 200 μM γ-DGG than the corresponding responses to
100 μM L-glutamate alone, but no difference was observed for
WT (2.2 ± 0.2 nA, n = 6) and Clcn3−/− (1.9 ± 0.1 nA, n = 5,
p = 0.2).
The frequency of mEPSCs critically depends on the num-
ber of synapses in our experimental system. We determined the
numbers of synapses for WT and mutant neurons by identify-
ing dendrites by MAP2 staining, and determining the density of
synapses as number of VGLUT1-positive dots per 50 μm dendrites
(Figures 5F,G). This approach provided similar synapse numbers
for WT and Clcn3−/− (p = 0.36). Taken together, these results
indicate that neither the number of synapses nor expression lev-
els/sensitivity of AMPA receptors and VGLUTs differ in WT and
Clcn3−/− neurons.
DISCUSSION
We here used patch clamp recordings on cultured WT and
Clcn3−/− neurons study the role of ClC-3 in glutamatergic
synaptic transmission. We found that miniature (Figure 1)
as well as evoked (Figure 3) excitatory postsynaptic currents
exhibit significantly higher amplitude in Clcn3−/− as in WT
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FIGURE 5 | Synaptogenesis and expression of AMPA receptors and
VGLUT1 are not altered in Clcn3−/− neurons. (A) Cumulative mean
intensity distribution and superimposed cumulative intensity probability of
VGLUT1 staining at synapses for WT and Clcn3−/−. (B) Mean
fluorescence intensity for VGLUT1 staining from Clcn3−/− (n = 943
synapses) and WT (n = 724 synapses, p = 0.6, t-test) synapses. (C)
Analysis of the VGLUT1 mRNA levels using quantitative qRT-PCR for WT
and Clcn3−/− neurons (four different cultures, p = 0.52, t -student). (D)
Surface and total expression levels of GluR1 in WT and Clcn3−/−
neurons determined by biotinylation and western blot analysis. (E) Mean
fraction of biotinlylated GluR1 from WT and Clcn3−/− neurons.
Means ± SEM from at least four different cultures. (F) Representative
epifluorescence images of WT and Clcn3−/− neurons after
immunolabeling with antibodies to the vesicular glutamate transporter 1
(VGLUT1) and anti-MAP2. (G) Mean synapse density ± SEM quantified
as number of VGLUT1 positive puncta per 50 μm dendrite length
identified by MAP2 staining from WT and Clcn3−/− neuronal cultures
(n = 17–20 per condition, p = 0.36, t -student).
neurons. Pharmacological approaches demonstrated higher gluta-
mate concentration in Clcn3−/− than at WT synapses (Figure 2).
These changes in glutamate release are not caused by altered
VGLUT1 expression in our cultures (Figures 5A–C), and we
thus conclude that ClC-3 regulates the amount of released
glutamate by increasing the driving force for vesicular gluta-
mate transport. We furthermore observed twofold increased
mEPSC frequency (Figure 1), but unchanged synaptic den-
sity in Clcn3−/− cultures (Figures 5F,G). Paired pulse ratios
were significantly reduced in Clcn3−/− as compared with
the WT neurons (Figures 3E,F), whereas the size of the
RRP was not affected (Figures 3C,D) by the genetic ablation
of ClC-3. Taken together, these results indicate that ClC-
3 increases the likelihood of synaptic vesicle fusion without
interfering with the establishment of the vesicle’s release-ready
state.
Earlier experiments revealed no significant differences in mean
amplitudes of miniature EPSCs or IPSCs from Clcn3−/− and
WT neurons (Stobrawa et al., 2001). These experiments were per-
formed on acute slices from Clcn3−/− animals at developmental
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stages at which degenerative changes are already occurring and at
which expression levels of VGLUT (VGLUT1) were found to be
decreased (Stobrawa et al., 2001). The differences between these
and our results are likely due to a neurodegeneration-associated
reduction in VGLUT1 expression.
ClC-3 was reported to function as voltage-dependent anion-
proton exchangers by several groups (Li et al., 2002; Guzman
et al., 2013). Since ClC-3 is expressed in SV (Stobrawa et al., 2001;
Gronborg et al., 2010), lack of ClC-3-mediated chloride-proton
exchanger might reduce vesicular counter ion movement and
result in increased depolarization of SV by electrogenic V-type
ATPases. ClC-3 exhibits a large probability of incomplete trans-
port cycle resulting in prominent capacitive current transients at
voltages in the range of synaptic vesicle potentials (Guzman et al.,
2013). This property will result in larger vesicular capacitances and
therefore in less depolarized vesicular membrane potentials of WT
than of Clcn3−/− neurons. Chloride/proton exchange as well as
capacitor function of ClC-3 will diminish the driving force for
VGLUTs (Guzman et al., 2013) that are mainly driven by the vesic-
ular membrane potential (Maycox et al., 1988). These effects are
consistent with the observed increase of glutamate accumulation
in Clcn3−/− SV.
The neurotransmitter content of SV is in dynamic equilib-
rium between transporter-mediated accumulation and leakage
(Williams,1997; Takamori,2006). Genetic ablationof ClC-3might
enhance the osmotic gradient across the vesicular membrane via
stimulating neurotransmitter accumulation and thus cause water
influx and vesicular growth (Colliver et al., 2000; Pothos et al.,
2000; Daniels et al., 2004). Increased glutamate accumulation and
water influx into SV will reach a new equilibrium at higher values
for both parameters and thus account for the observed difference
in vesicle volume between WT and Clcn3−/− neurons.
We observed a twofold increasemEPSC frequency inClcn3−/−
that was not a consequence of an enhanced synaptic density
(Figures 5F,G). Reduction in paired pulse ratio (Figures 3E,F)
together with the unchanged size of RRP in Clcn3−/− neu-
ronal cultures (Figures 3C,D) indicates that genetic ablation
of ClC-3 proteins does not interfere with the establishment
of the vesicle’s release-ready state. A possible explanation for
the increased likelihood of synaptic vesicle fusion observed in
Clcn3−/− synapses might be synaptic vesicle swelling due to
increased glutamate accumulation. For many years, it has been
known that osmotic swelling is a driving force for the fusion
of vesicles with planar bilayers (Cohen et al., 1982; Akabas
et al., 1984). It is tempting to speculate that enhanced glu-
tamate accumulation might directly result in increased vesi-
cle fusion in Clcn3−/−neurons via osmotic swelling. Alter-
natively, ClC-3 might regulate vesicle fusion via – yet to be
defined - interacting protein partners in the presynaptic nerve
terminal.
Our conclusion that ClC-3 restricts glutamate accumulation
in SV could be further substantiated by rescuing experiments
with Clcn3−/− neurons that express ClC-3 after viral infection.
Unfortunately, the existence of multiple splice ClC-3 variants with
probably distinct function and localization (Ogura et al., 2002;
Gentzsch et al., 2003; Guzman et al., 2013) makes such experi-
ments currently unfeasible. The identification of all ClC-3 splice
variants together with their corresponding subcellular distribu-
tion will be an important step to further understand the precise
role of this CLC isoform in synaptic transmission.
Our results demonstrate that genetic ablation of ClC-3
enhances the driving force for vesicular glutamate accumulation
and thus assign a presynaptic role in regulating the vesicular glu-
tamate concentration to ClC-3. However, there are also reports on
postsynaptic localization of this protein. Wang et al. (2006) postu-
lated that ClC-3 forms a postsynaptic CaMKII-activated chloride
channel. ClC-3 functioning as anion channels was postulated
to modify neuronal excitability by providing a regulated post-
synaptic anion conductance that protects form excessive Ca2+
influx via NMDA receptors (Wang et al., 2006; Farmer et al.,
2012). The authors speculated that absent ClC-3 increases NMDA
signals even when presynaptic glutamate release is reduced (Sto-
brawa et al., 2001) and thus results in neurodegeneration in
Clcn3−/− mice. There are different ClC-3 splice variants that may
have multiple functional properties and localize to distinct neu-
ronal compartments (Ogura et al., 2002; Gentzsch et al., 2003).
Although our data strongly support presynaptic localization and
anion-proton exchanger function of at least certain ClC-3 splice
variants (Guzman et al., 2013), it is possible that other splice
variants may function as anion channels in the postsynaptic
compartments.
In conclusion, we here demonstrate that ClC-3 proteins mod-
ulate synaptic strength at glutamatergic synapses by regulating
the amount of neurotransmitter stored in a single synaptic vesicle
as well as its likelihood of fusion. These findings assign a presy-
naptic role in regulating glutamate release to ClC-3. Our results
suggest that ClC-3 functions as safety measure to prevent glu-
tamate excitotoxicity in WT animals and that excessive release
of glutamate contributes to neurodegeneration in Clcn3−/−
mice.
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